Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to the
global pandemic of Coronavirus Disease (2019)(COVID-19), underscoring the urgency for …

Ivermectin was first approved for human use as an endectocide in the 1980s. It remains one
of the most important global health medicines in history and has recently been shown to …

More than two years have passed since the viral outbreak that led to the novel infectious
respiratory disease COVID-19, caused by the SARS-CoV-2 coronavirus. Since then, the …

Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity
against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported …

Ivermectin is an FDA approved drug and showed in vitro antiviral activity against different
serotypes of Foot-and-mouth disease virus (FMDV). We here assessed the effect of …

Since it was proposed as a potential host-directed antiviral agent for SARS-CoV-2, the
antiparasitic drug ivermectin has been investigated thoroughly in clinical trials, which have …

The emergence of multidrug-resistant strains requires the urgent discovery of new
antibacterial drugs. In this context, an antibacterial screening of a subset of anthelmintic …

Cellular susceptibility to SARS-CoV-2 infection in the respiratory tract has been associated
with the ability of the virus to interact with potential receptors on the host membrane. We …

Recent reports have suggested that the susceptibility of cells to SARS-CoV-2 infection can
be influenced by various proteins that potentially act as receptors for the virus. To investigate …

Background Two recent publications by Kerr et al.(Cureus 14 (1): e21272; Cureus 14 (8):
e28624) reported dramatic effects of prophylactic ivermectin use for both prevention of …